Scarica l'app Stockscreener
4.11
8.67%
-0.39
Dopo l'orario di chiusura:
4.12
0.010
+0.24%
Precedente Chiudi:
$4.50
Aprire:
$4.46
Volume 24 ore:
56,854
Relative Volume:
1.33
Capitalizzazione di mercato:
$74.84M
Reddito:
-
Utile/perdita netta:
$-9.46M
Rapporto P/E:
-0.142
EPS:
-28.9457
Flusso di cassa netto:
$-8.70M
1 W Prestazione:
-9.07%
1M Prestazione:
-9.57%
6M Prestazione:
+13.54%
1 anno Prestazione:
-18.97%
Intervallo 1D:
$4.11
$4.46
Intervallo di 1 settimana:
$4.11
$4.64
Portata 52W:
$2.66
$5.8922
Alterity Therapeutics Ltd Adr Stock (ATHE) Company Profile
Nome
Alterity Therapeutics Ltd Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare ATHE vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATHE
Alterity Therapeutics Ltd Adr
|
4.11 | 81.94M | 0 | -9.46M | -8.70M | -28.95 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alterity Therapeutics Ltd Adr Stock (ATHE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-03 | Downgrade | The Benchmark Company | Speculative Buy → Hold |
| 2024-12-12 | Iniziato | Maxim Group | Buy |
Alterity Therapeutics Ltd Adr Borsa (ATHE) Ultime notizie
Immuron LimitedADR (IMRN) Peer Comparison – Compare with Others - Value Research
Alterity Therapeutics Reports A$17.6M in R&D Expenses for Fiscal Year Ending June 30, 2026 - Kalkine Media
Kazia Therapeutics LimitedADR Peer Comparison – Compare with Others - Value Research
Alterity Therapeutics Limited (ASX:ATH) Share Price Falls 4.46% as Stock Trades Within Daily Range - Kalkine
Alterity Therapeutics Secures Key US Patent for Lead Asset - Sahm
Alterity Therapeutics at Canaccord conference: phase III path in focus By Investing.com - Investing.com India
Alterity Therapeutics at Canaccord conference: phase III path in focus - Investing.com
Craig-Hallum initiates Alterity Therapeutics stock coverage with buy rating - Investing.com
Acrux Ltd (ASX:ACR) Share Price Update: Trading Snapshot for 11 August 2026 - Kalkine
Alterity Therapeutics (ATHE) Gains 1.24% to $4.5, Holding Above Key SupportFibonacci Fan - vinanet.vn
PRNAF SEC FilingsALTERITY THERAPEUTICS LTD 10-K, 10-Q, 8-K Forms - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Weiss Ratings Stock Recommendations & Analyst Ratings 2026 - MarketBeat
ATHE News | ALTERITY THERAPEUTICS-ADR (NASDAQ:ATHE) - ChartMill
[6-K] ALTERITY THERAPEUTICS LTD Current Report (Foreign Issuer) | ATHE SEC FilingForm 6-K - Stock Titan
Jones Trading initiates Alterity Therapeutics stock with buy rating - Investing.com
Alteriry Therapeutics Ltd Sponsored ADR Actuals & Estimates (NASDAQ:ATHE) - TradingView
Is Allarity Therapeutics, Inc. (ALLR) outperforming other medical stocks this year? - MSN
Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Alterity Therapeutics Advances Lead Drug Towards Pivotal Study For Rare Neuromuscular Disorder - Sahm
Insights: Alterity Therapeutics Ltd (ASX:ATHDA) - smallcaps.com.au
ATHEAlterity Therapeutics Ltd ADR Short Interest - Finviz
Alterity Therapeutics (NASDAQ: ATHE) sets vote on 50:1 consolidation and large option, incentive issuances - Stock Titan
Alterity Therapeutics appoints Ann Cunningham to board - Investing.com
Alterity Therapeutics appoints Ann Cunningham to board By Investing.com - Investing.com India
Nerves settle as oil drops - The Cairns Post
Alterity Therapeutics Receives Positive FDA Feedback for ATH434 Phase 3 MSA Program - smallcaps.com.au
ATA Inc. (NASDAQ:AACG) Sees Large Decline in Short Interest - Defense World
Actelis Networks, Inc. (NASDAQ:ASNS) Sees Large Decline in Short Interest - Defense World
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 188.7% in February - Defense World
Ameritas Investment Partners Inc. Raises Stock Holdings in Kratos Defense & Security Solutions, Inc. $KTOS - Defense World
Alterity Therapeutics (NASDAQ:ATHE) Upgraded at Zacks Research - Defense World
Insights: Alterity Therapeutics Ltd (ASX:ATH) - smallcaps.com.au
Alterity Therapeutics (ATHE) Presents Positive Phase 2 Data for ATH434 - Finviz
Quantum Biopharma (QNTM) Short Interest & Short Float | Updated May 2026 - MarketBeat
Liminatus Pharma (LIMN) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Jason McCarthy Analyst Performance at Maxim Group - MarketBeat
ATHE SEC FilingsAlterity Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead
Alterity Therapeutics LtdADR (ATHE) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
- SEC.gov
Cadrenal Therapeutics (CVKD) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Bullfrog AI (BFRG) Short Interest & Short Float | Updated Apr 2026 - MarketBeat
Imunon (IMNN) Short Interest & Short Float | Updated May 2026 - MarketBeat
What is the current Price Target and Forecast for Alterity Therapeutics LimitedSponsored ADR (ATHE) - Zacks Investment Research
Mainz Biomed (MYNZ) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
These stocks are moving in today's pre-market session - ChartMill
Portage Biotech (PRTG) Short Interest & Short Float | Updated Apr 2026 $PRTG - MarketBeat
Which stocks are gapping on Wednesday? - ChartMill
Which stocks are moving before the opening bell on Thursday? - ChartMill
Friday's session: gap up and gap down stocks - ChartMill
Alterity Therapeutics Ltd Adr Azioni (ATHE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):